---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-029355"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T17:01:14.218519+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Strata seeks CMS temporary codes for expanded XTRAC reimbursement; triples addressable market to 30M+

## Summary
- Working with CMS to secure temporary codes for expanded CPT codes for XTRAC, aiming for 2026 reimbursement instead of 2027.
- Expanded coding triples addressable patient population to over 30M for inflammatory and autoimmune skin conditions.
- Two new studies show excimer laser plus JAK inhibitors safe and effective for vitiligo, supporting XTRAC use.
- Federal court adds LaserOptek Korea and C. Dalton as defendants in false advertising lawsuit; STRATA encouraged by ruling.

## SEC filing metadata
- accession: 0001140361-25-029355
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000114036125029355/0001140361-25-029355-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000114036125029355/ef20053379_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-029355
- JSON: https://secwatch.observer/filing/0001140361-25-029355.json
- Plain text: https://secwatch.observer/filing/0001140361-25-029355.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.